Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-07-143071
Filing Date
2007-06-26
Accepted
2007-06-26 16:56:45
Documents
5
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM 10-K d10ka.htm 10-K/A 1461699
2 CONSENT OF SINGER, LEWAK, GREENBAUM & GOLDSTEIN LLP dex23.htm EX-23 1967
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 6870
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 7362
5 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex32.htm EX-32 6414
  Complete submission text file 0001193125-07-143071.txt   1485775
Mailing Address 1635 VILLAGE CENTER CIRCLE SUITE 250 LAS VEGAS NV 89134
Business Address 1635 VILLAGE CENTER CIRCLE SUITE 250 LAS VEGAS NV 89134 702-248-1174
CardioVascular BioTherapeutics, Inc. (Filer) CIK: 0001303497 (see all company filings)

EIN.: 330795984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-51172 | Film No.: 07941629
SIC: 2834 Pharmaceutical Preparations